Freestone N S, Heubach J F, Wettwer E, Ravens U, Brown D, Kaumann A J
Laboratory of Molecular Signalling, The Babraham Institute, Cambridge, UK.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Oct;360(4):445-56. doi: 10.1007/s002109900075.
Putative beta4-adrenoceptors mediate cardiostimulation and arrhythmias in mammalian heart. Both beta1- and putative beta4-adrenoceptors mediate arrhythmias but through different mechanisms. To elucidate further the mechanisms of cardiostimulation and arrhythmias we measured Ca2+ transients and L-type Ca2+ currents in mouse ventricular myocytes. We used (-)-CGP 12177, an antagonist of beta1- and beta2-adrenoceptors with agonist properties at the putative beta4-adrenoceptor, and (-)-isoprenaline as an agonist for beta1- and beta2-adrenoceptors. (-)-CGP 12177 increased Ca2+ transients in electrically stimulated cells loaded with Indo-1. The maximum increase of Ca2+ transients caused by (-)-CGP 12177 amounted to approximately one-third of that caused by maximally effective (-)-isoprenaline concentrations. Both (-)-CGP 12177 and (-)-isoprenaline caused concentration-dependent arrhythmic Ca2+ transients. The arrhythmias appeared at paced Ca2+ transients and between paced Ca2+ transients. The arrhythmic potency of (-)-CGP 12177 (-logEC50=9.4) was approximately 40 times greater than that of (-)-isoprenaline (-logEC50=7.8). L-type Ca2+ current was measured in the whole cell configuration of the patch clamp technique. In the presence of both 3-isobutyl 1-methylxanthine (6 micromol/l) and (-)-propranolol (500 nmol/l), (-)-CGP 12177 (100 nmol/l) increased significantly L-type Ca2+ current by 19% of the effect of (-)-isoprenaline. The (-)-CGP 12177-evoked increase of Ca2+ transients contrasts with the smaller effects on L-type Ca2+ current, suggesting that activation of the putative beta4-adrenoceptor causes a more efficient Ca2+-induced Ca2+ release than activation of the beta1-adrenoceptor. Beta4-Adrenoceptors mediate arrhythmias with smaller Ca2+ transients and smaller increases of L-type Ca2+ current than beta1-adrenoceptors, in line with different but still unknown mechanisms as previously suggested for the intact heart.
推测的β4 - 肾上腺素能受体介导哺乳动物心脏的心脏刺激和心律失常。β1 - 肾上腺素能受体和推测的β4 - 肾上腺素能受体均介导心律失常,但机制不同。为了进一步阐明心脏刺激和心律失常的机制,我们测量了小鼠心室肌细胞中的Ca2 + 瞬变和L型Ca2 + 电流。我们使用了( - ) - CGP 12177,一种β1 - 和β2 - 肾上腺素能受体拮抗剂,对推测的β4 - 肾上腺素能受体具有激动剂特性,以及( - ) - 异丙肾上腺素作为β1 - 和β2 - 肾上腺素能受体的激动剂。( - ) - CGP 12177增加了用Indo - 1加载的电刺激细胞中的Ca2 + 瞬变。( - ) - CGP 12177引起的Ca2 + 瞬变的最大增加量约为最大有效浓度的( - ) - 异丙肾上腺素引起的增加量的三分之一。( - ) - CGP 12177和( - ) - 异丙肾上腺素均引起浓度依赖性心律失常性Ca2 + 瞬变。心律失常出现在起搏的Ca2 + 瞬变期间和起搏的Ca2 + 瞬变之间。( - ) - CGP 12177的心律失常效力( - logEC50 = 9.4)比( - ) - 异丙肾上腺素( - logEC50 = 7.8)大约强40倍。在膜片钳技术的全细胞配置中测量L型Ca2 + 电流。在存在3 - 异丁基 - 1 - 甲基黄嘌呤(6 μmol / l)和( - ) - 普萘洛尔(500 nmol / l)的情况下,( - ) - CGP 12177(100 nmol / l)使L型Ca2 + 电流显著增加,增加幅度为( - ) - 异丙肾上腺素作用的19%。( - ) - CGP 12177引起的Ca2 + 瞬变增加与对L型Ca2 + 电流的较小影响形成对比,表明推测的β4 - 肾上腺素能受体的激活比β1 - 肾上腺素能受体的激活引起更有效的Ca2 + 诱导的Ca2 + 释放。与β1 - 肾上腺素能受体相比,β4 - 肾上腺素能受体介导的心律失常具有较小的Ca2 + 瞬变和较小的L型Ca2 + 电流增加,这与之前对完整心脏提出的不同但仍未知的机制一致。